ATE395344T1 - Kalzilytische verbindungen - Google Patents
Kalzilytische verbindungenInfo
- Publication number
- ATE395344T1 ATE395344T1 AT04784821T AT04784821T ATE395344T1 AT E395344 T1 ATE395344 T1 AT E395344T1 AT 04784821 T AT04784821 T AT 04784821T AT 04784821 T AT04784821 T AT 04784821T AT E395344 T1 ATE395344 T1 AT E395344T1
- Authority
- AT
- Austria
- Prior art keywords
- calcilytic compounds
- calcilytic
- compounds
- Prior art date
Links
- 230000001126 calcilytic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50600103P | 2003-09-24 | 2003-09-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE395344T1 true ATE395344T1 (de) | 2008-05-15 |
Family
ID=34393099
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04784821T ATE395344T1 (de) | 2003-09-24 | 2004-09-23 | Kalzilytische verbindungen |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20070203226A1 (de) |
| EP (1) | EP1664013B1 (de) |
| JP (1) | JP2007506751A (de) |
| AR (1) | AR045799A1 (de) |
| AT (1) | ATE395344T1 (de) |
| DE (1) | DE602004013802D1 (de) |
| ES (1) | ES2303099T3 (de) |
| TW (1) | TW200524892A (de) |
| WO (1) | WO2005030749A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY143244A (en) * | 2002-11-26 | 2011-04-15 | Smithkline Beecham Corp | Calcilytic compounds |
| US20090304821A1 (en) * | 2006-03-08 | 2009-12-10 | Takeda Pharmaceutical Company Limited | Pharmaceutical Combination |
| CA2663436A1 (en) | 2006-10-04 | 2008-04-10 | Pfizer Products Inc. | Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists |
| AU2009255156B2 (en) | 2008-06-05 | 2013-03-14 | Asahi Kasei Pharma Corporation | Sulfonamide compound and application thereof |
| GB201217330D0 (en) | 2012-09-28 | 2012-11-14 | Univ Cardiff | Therapeutic for treating inflammatory lung disorders |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3239342A (en) * | 1965-02-15 | 1966-03-08 | Commercial Solvents Corp | Estrogenic compounds and animal growth promoters |
| JP2001510838A (ja) * | 1997-07-25 | 2001-08-07 | アメリカ合衆国 | マクロサイクリックラクトン、組成物、および使用方法 |
| ID28460A (id) * | 1998-07-08 | 2001-05-24 | Lipogenics Inc | Komposisi dan metoda untuk perlakuan dan pencegahan penyakit tulang dengan menggunakan tocotrienol |
| JP2003113183A (ja) * | 2001-10-05 | 2003-04-18 | Kyowa Hakko Kogyo Co Ltd | リウマチ治療剤 |
-
2004
- 2004-09-22 AR ARP040103411A patent/AR045799A1/es not_active Application Discontinuation
- 2004-09-22 TW TW093128647A patent/TW200524892A/zh unknown
- 2004-09-23 US US10/572,669 patent/US20070203226A1/en not_active Abandoned
- 2004-09-23 AT AT04784821T patent/ATE395344T1/de not_active IP Right Cessation
- 2004-09-23 EP EP04784821A patent/EP1664013B1/de not_active Expired - Lifetime
- 2004-09-23 JP JP2006528144A patent/JP2007506751A/ja active Pending
- 2004-09-23 ES ES04784821T patent/ES2303099T3/es not_active Expired - Lifetime
- 2004-09-23 DE DE602004013802T patent/DE602004013802D1/de not_active Expired - Lifetime
- 2004-09-23 WO PCT/US2004/031120 patent/WO2005030749A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005030749A1 (en) | 2005-04-07 |
| EP1664013A1 (de) | 2006-06-07 |
| AR045799A1 (es) | 2005-11-16 |
| US20070203226A1 (en) | 2007-08-30 |
| ES2303099T3 (es) | 2008-08-01 |
| TW200524892A (en) | 2005-08-01 |
| EP1664013B1 (de) | 2008-05-14 |
| EP1664013A4 (de) | 2007-03-14 |
| DE602004013802D1 (de) | 2008-06-26 |
| JP2007506751A (ja) | 2007-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2023008I2 (el) | Χημικες ενωσεις | |
| ATE549329T1 (de) | Chinazoline verbindungen | |
| DK1605897T3 (da) | Polyethelen-glycol-link-glp-1-forbindelser | |
| SE0302305D0 (sv) | Novel Compounds | |
| IS8108A (is) | Ný efnasambönd | |
| IS8513A (is) | Lífræn efnasambönd | |
| NO20055688D0 (no) | Organiske forbindelser | |
| IS8228A (is) | Ný asetídínefnasambönd | |
| IS8089A (is) | Efnasambönd | |
| DK1651034T3 (da) | Organiske forbindelser | |
| IS8292A (is) | Ný efnasambönd | |
| DK1569892T3 (da) | Kalcilytiske forbindelser | |
| DE602004013802D1 (de) | Kalzilytische verbindungen | |
| NO20031736D0 (no) | Forbindelser | |
| NO20034952D0 (no) | Farmasöytiske forbindelser | |
| SE0303452D0 (sv) | New compounds | |
| NO20055170D0 (no) | Organiske forbindelser | |
| NO20033173D0 (no) | Forbindelser | |
| NO20030117D0 (no) | Forbindelser | |
| NO20035294D0 (no) | Forbindelser | |
| SE0302667D0 (sv) | Novel Compounds | |
| SE0300388D0 (sv) | Novel compounds | |
| SE0300118D0 (sv) | Novel Compounds | |
| SE0300357D0 (sv) | New compounds | |
| SE0303182D0 (sv) | New compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |